Moderna

With pharmaceutical companies awaiting federal clearance to make their modified COVID boosters available to children, Moderna’s Chief Medical Officer Dr. Paul Burton discusses its importance.

As thousands of people in the Bay Area roll up their sleeves for the latest COVID booster shot, those searching for the Moderna booster are struggling to even get an appointment. Marianne Favro reports.

Yes, health officials expect another spike in coronavirus cases this fall, but they also point out the nation is in a much different place today than in years past due to tools doctors now have to fight the virus. “We are in a much, much better place. We are in a better place because people have gotten vaccinated and boosted….

The U.S. Food and Drug Administration authorized a pair of new COVID-19 boosters that specifically target omicron subvariants, and rollout could be as early as Monday pending CDC clearance. Ginger Conejero Saab reports.

U.S. federal regulators on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope is that the modified boosters will blunt yet another winter...

A brand new COVID-19 booster could be available as soon as next week — one that protects against the original strain of coronavirus, along with the newer, more contagious strains. NBC Bay Area’s Raj Mathai spoke to Dr. Peter Chin-Hong of UCSF for some insight.

New coronavirus variants have emerged and are starting to gain ground across the globe. Meanwhile, the White House provides a timeline on when updated COVID-19 boosters will be available.

The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.

UCSF infectious disease expert Dr. Peter Chin Hong says a possible twindemic with flu season and the ongoing COVID pandemic is more probable this year and urges people to get a flu shot.

Moderna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its Covid booster shot.

The Biden administration says it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine targeting the highly transmissible omicron variant.

Pfizer-BioNTech and Moderna vaccines are safe and effective for children 6 months old and up, clearing the way for its use in California, Nevada, Oregon and Washington, the Western States Scientific Safety Review Workgroup announced Sunday afternoon.

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17. A vaccine made by Pfizer has been available since last year for those ages. The Food and Drug...

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.